IPCA Laboratories Limited (IN:IPCALAB)
:IPCALAB
Want to see IN:IPCALAB full AI Analyst Report?
Total Valuation
IPCA Laboratories Limited has a market cap or net worth of ₹402.25B. The enterprise value is ₹389.19B.
Market Cap₹402.25B
Enterprise Value₹389.19B
Share Statistics
IPCA Laboratories Limited has 253,659,230 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding253,659,230
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
IPCA Laboratories Limited’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 16.49%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)16.49%
Return on Capital Employed (ROCE)0.23
Revenue Per Employee5.56M
Profits Per Employee907.14K
Employee Count17,335
Asset Turnover0.78
Inventory Turnover1.27
Valuation Ratios
The current PE Ratio of IPCA Laboratories Limited is 35.2. IPCA Laboratories Limited’s PEG ratio is 0.65.
PE Ratio35.2
PS Ratio4.21
PB Ratio5.04
Price to Fair Value5.04
Price to FCF83.57
Price to Operating Cash Flow51.48
PEG Ratio0.65
Income Statement
In the last 12 months, IPCA Laboratories Limited had revenue of 96.46B and earned 11.41B in profits. Earnings per share was 44.98.
Revenue96.46B
Gross Profit61.83B
Operating Income23.32B
Pretax Income15.68B
Net Income11.41B
EBITDA19.54B
Earnings Per Share (EPS)44.98
Cash Flow
In the last 12 months, operating cash flow was 7.80B and capital expenditures -4.61B, giving a free cash flow of 3.19B billion.
Operating Cash Flow7.80B
Free Cash Flow3.19B
Free Cash Flow per Share12.56
Dividends & Yields
IPCA Laboratories Limited pays an annual dividend of ₹2, resulting in a dividend yield of 0.28%
Dividend Per Share₹2
Dividend Yield0.28%
Payout Ratio4.90%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.13
52-Week Price Change16.58%
50-Day Moving Average1.54K
200-Day Moving Average1.45K
Relative Strength Index (RSI)50.70
Average Volume (3m)6.78K
Important Dates
IPCA Laboratories Limited upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 29, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
IPCA Laboratories Limited as a current ratio of 2.76, with Debt / Equity ratio of 10.03%
Current Ratio2.76
Quick Ratio1.58
Debt to Market Cap0.02
Net Debt to EBITDA0.12
Interest Coverage Ratio30.70
Taxes
In the past 12 months, IPCA Laboratories Limited has paid 3.84B in taxes.
Income Tax3.84B
Effective Tax Rate0.24
Enterprise Valuation
IPCA Laboratories Limited EV to EBITDA ratio is 20.91, with an EV/FCF ratio of 84.07.
EV to Sales4.24
EV to EBITDA20.91
EV to Free Cash Flow84.07
EV to Operating Cash Flow35.78
Balance Sheet
IPCA Laboratories Limited has ₹12.83B in cash and marketable securities with ₹12.79B in debt, giving a net cash position of ₹39.80M billion.
Cash & Marketable Securities₹12.83B
Total Debt₹12.79B
Net Cash₹39.80M
Net Cash Per Share₹0.16
Tangible Book Value Per Share₹367.67
Margins
Gross margin is 64.10%, with operating margin of 24.17%, and net profit margin of 11.83%.
Gross Margin64.10%
Operating Margin24.17%
Pretax Margin16.25%
Net Profit Margin11.83%
EBITDA Margin20.25%
EBIT Margin16.00%
Analyst Forecast
The average price target for IPCA Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast7.91%
EPS Growth Forecast54.70%